Alexa Fluor® 488 anti-mouse/rat/human FOXP3

Antibodies Single
Sony
150D
Flow Cytometry
Mouse IgG1, κ
Rat
Full-length FOXP3 protein
2200060
$365.00

Description

FOXP3 is a 50-55 kD transcription factor, also known as Forkhead box protein P3, Scurfin, JM2, or IPEX. It is proposed to be a master regulatory gene and more specific marker of T regulatory cells than most cell surface markers (such as CD4 and CD25). Transduced expression of FOXP3 in CD4+/CD25- cells has been shown to induce GITR, CD103, and CTLA4 and impart a T regulatory cell phenotype. FOXP3 is mutated in X-linked autoimmunity-allergic dysregulation syndrome (XLAAD or IPEX) in humans and in "scurfy" mice. Overexpression of FOXP3 has been shown to lead to a hypoactive immune state suggesting that this transcriptional factor is a central regulator of T cell activity. In human, unlike in mouse, two isoforms of FOXP3 have been reported: one (FOXP3) corresponding to the canonical full-length sequence; the other (FOXP3 δ2) lacking exon 2. The 150D monoclonal antibody reacts with human, mouse and rat FOXP3. The 150D antibody recognizes FOXP3 epitope encoded by exon 2.

Formulation

Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and 0.2% (w/v) BSA (origin USA).

Recommended Usage

Each lot of this antibody is quality control tested by intracellular flow cytometry . For flow cytometric staining, the suggested use of this reagent is 5 microL per 106 cells in 100 microL volume. It is recommended that the reagent be titrated for optimal performance for each application.

* Alexa Fluor® 488 has a maximum emission of 519 nm when it is excited at 488 nm.

References

1. Roncador G, et al. 2005 Eur. J. Immunol. 35:1681.
2. Mayack. S,et al. 2006. J. Immunol.176:2059. J. Immunol
3. Yang ZZ, et al. 2006. Blood 107:3639.
4. Gavin MA, et al. 2006. P. Natl. Acad. Sci. USA 103:6659.
5. Groh V, et al. 2006. Nature Immunology 7:755.
6. Lewkowicz P, et al. 2006 J. Immunol. 177:7155.
7. Luke PPW, et al. 2006. Amer. J. Transplant. 6(9):2023.
8. Bamias G, et al. 2007. J. Immunol. 178:1809.
9. Valencia X, et al. 2007. J. Immunol. 178:2579.PubMed
10. Davidson TS, et al. 2007. J. Immunol. 178:4022.
11. MacDonald K PA, et al. 2007. Blood doi:10.1182/blood-2007-01-067249.
12. Jaffar Z, et al. 2007. J. Immunol. 179:6193.
13. Müller M, et al. 2007. J. Immunol. 179:2774.
14. Jordan JM,et al. 2008.Infect Human. 76:3717. PubMed
15.Golovina TN,et al. 2008. J. Immunol. 181:2855. PubMed
16. Fallarino F, et al. 2009. J. Exp Med. 206:2511. PubMed
17. Banham Alison, et al. 2009. Vet Immunol and Immunop 127.3-4:376-381
18. Klunker S, et al. 2009. J. Exp Med. PubMed
19. Haque A, et al. 2010. J. Immunol. 184:2583. PubMed
20. Liu Y, et al. 2013. J Mol Cell Biol. PubMed
21. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
22. Xie L, et al. 2014. J Immunol. 192:6009. PubMed
23. Prado-Garcia H, et al. 2015. Anticancer Res.35:1529. PubMed